CURRENT REPORT UNDER SECTION 17 OF THE SECURITIES REGULATION CODE AND SRC RULE 17.2(c) THEREUNDER
1. Date of Report (Date of earliest event reported)
Nov 24, 2025
2. SEC Identification Number
175222
3. BIR Tax Identification No.
242-603-734-000
4. Exact name of issuer as specified in its charter
Vivant Corporation
5. Province, country or other jurisdiction of incorporation
Mandaluyong City
6. Industry Classification Code(SEC Use Only)
7. Address of principal office
9th Floor, Oakridge IT Center 3, Oakridge Business Park, A.S. Fortuna Street, Barangay Banilad, Mandaue City, CebuPostal Code6014
8. Issuer's telephone number, including area code
(032) 234-2256; (032) 234-2285
9. Former name or former address, if changed since last report
Not applicable
10. Securities registered pursuant to Sections 8 and 12 of the SRC or Sections 4 and 8 of the RSA
Title of Each Class
Number of Shares of Common Stock Outstanding and Amount of Debt Outstanding
Common shares
1,023,456,698
11. Indicate the item numbers reported herein
9
The Exchange does not warrant and holds no responsibility for the veracity of the facts and representations contained in all corporate disclosures, including financial reports. All data contained herein are prepared and submitted by the disclosing party to the Exchange, and are disseminated solely for purposes of information. Any questions on the data contained herein should be addressed directly to the Corporate Information Officer of the disclosing party.
Vivant CorporationVVT
PSE Disclosure Form 4-4 - Amendments to By-Laws References: SRC Rule 17 (SEC Form 17-C) and Section 4.4 of the Revised Disclosure Rules
Subject of the Disclosure
Amendment of By-Laws
Background/Description of the Disclosure
This is an amendment to the previous disclosures posted in the Exchange through Reports No. C04475-2025, and C07578-2025.
Vivant Corporation (the “Company”) informs the public and the Exchange that it has received the Certificate of Amendment of By-Laws from the Securities and Exchange Commission on November 24, 2025.
Date of Approval by Board of Directors
Mar 21, 2025
Date of Approval by Stockholders
Jun 19, 2025
Other Relevant Regulatory Agency, if applicable
N/A
Date of Approval by Relevant Regulatory Agency, if applicable
N/A
Date of Approval by Securities and Exchange Commission
Nov 19, 2025
Date of Receipt of SEC approval
Nov 24, 2025
Amendment(s)
Article and Section Nos.
From
To
Article II, Section 1
-
Kindly see the attached SEC Form No. 17-C
Article II Section 6
-
Kindly see the attached SEC Form No. 17-C
Article III, Section 1
-
Kindly see the attached SEC Form No. 17-C
Article III, Section 4
-
Kindly see the attached SEC Form No. 17-C
Article III, Section 6
-
Kindly see the attached SEC Form No. 17-C
Article III, Section 7
-
Kindly see the attached SEC Form No. 17-C
Article V, Section 1
-
Kindly see the attached SEC Form No. 17-C
Article V, Section 3
-
Kindly see the attached SEC Form No. 17-C
Article V, Section 4
-
Kindly see the attached SEC Form No. 17-C
Article V, Section 7
-
Kindly see the attached SEC Form No. 17-C
Article V, Section 8
-
Kindly see the attached SEC Form No. 17-C
Article V, Section 9
-
Kindly see the attached SEC Form No. 17-C
Article V, Section 10
-
Kindly see the attached SEC Form No. 17-C
Rationale for the amendment(s)
1. Amendment of the date of the Annual Stockholder’s Meeting; 2. Provides additional powers to the Board of Directors to act as trustee or delegate trusteeship powers to other entities and enhancements to the implicit powers over key officers; 3. Alignment with organizational structure through specific identification of the roles and responsibilities relating the Chief Executive Officer, and the President; 4. Enhancements to quorum requirements; 5. Enhancements to rules on the tenure and functions of the Officers of the Corporation; and 6. Formal inclusion of the Treasurer position in the By-Laws.
The timetable for the effectivity of the amendment(s)
Expected date of filing the amendments to the By-Laws with the SEC
Oct 28, 2025
Expected date of SEC approval of the Amended By-Laws
Nov 24, 2025
Effect(s) of the amendment(s) to the business, operations and/or capital structure of the Issuer, if any
None
Other Relevant Information
For more information kindly refer to the attached Current Reports.